Comparison of Actual Performance in the Flow and Fraction of Inspired O2 among Different High-Flow Nasal Cannula Devices: A Bench Study
Background. High-flow nasal cannula (HFNC) oxygen therapy has been recommended for use in coronavirus disease 2019 (COVID-19) patients with acute respiratory failure and many other clinical conditions. HFNC devices produced by different manufacturers may have varied performance. Whether there is a d...
Main Authors: | Yuyan Zhou, Zhong Ni, Yuenan Ni, Binmiao Liang, Zongan Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2021/6638048 |
Similar Items
-
Flow Field Analysis of Adult High-Flow Nasal Cannula Oxygen Therapy
by: Jingen Xia, et al.
Published: (2021-01-01) -
High Flow Nasal Cannulae in preterm infants
by: F. Ciuffini, et al.
Published: (2013-06-01) -
High-flow nasal cannula: COVID 19 and beyond
by: Aniket Shitalkumar Rali, et al.
Published: (2020-01-01) -
High-flow nasal cannula for body rewarming in hypothermia
by: Emanuele Gilardi, et al.
Published: (2020-03-01) -
Effect of flow and cannula size on generated pressure during nasal high flow
by: Maximilian Pinkham, et al.
Published: (2020-05-01)